On the Pharmacotherapy of Sleep Bruxism: Placebo-Controlled Polysomnographic and Psychometric Studies with Clonazepam | Zendy

A. Saletu | Zendy; Silvia Parapatics | Zendy; B. Saletu | Zendy; P. Anderer | Zendy; Wolfgang Prause | Zendy; Hanna Putz | Zendy; Josef Adelbauer | Zendy; G. SaletuZyhlarz | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

On the Pharmacotherapy of Sleep Bruxism: Placebo-Controlled Polysomnographic and Psychometric Studies with Clonazepam

Author(s) -

A. Saletu,

Silvia Parapatics,

B. Saletu,

P. Anderer,

Wolfgang Prause,

Hanna Putz,

Josef Adelbauer,

G. SaletuZyhlarz

Publication year - 2005

Publication title -

neuropsychobiology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.71

H-Index - 83

eISSN - 1423-0224

pISSN - 0302-282X

DOI - 10.1159/000085917

Subject(s) - polysomnography , clonazepam , pittsburgh sleep quality index , epworth sleepiness scale , placebo , anxiety , psychology , insomnia , restless legs syndrome , sleep bruxism , physical therapy , medicine , anesthesia , psychiatry , electromyography , electroencephalography , alternative medicine , pathology , sleep quality

Sleep bruxism (SB) is a parasomnia defined as a stereotyped movement disorder characterized by grinding or clenching of the teeth during sleep. Pathophysiologically, SB is the result of biological and psychosocial influences. Treatment comprises behavioral, orthodontic and pharmacological interventions. While benzodiazepines and muscle relaxants have been reported by clinicians to reduce bruxism-related motor activity, placebo-controlled studies are lacking. Thus, the aim of the present study was to investigate the acute effects of clonazepam (Rivotril) as compared with placebo, utilizing polysomnography and psychometry.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research